SUMATRIPTAN ARROW 50 mg, tablet 6 tablets
Active ingredients: Sumatriptan succinate, Sumatriptan
Commercialized according to BDPMDispensing in France: Prescription only
Tablet6 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- SUMATRIPTAN ARROW 50 mg, comprimé
- Pharmaceutical form
- comprimé
- Route of administration
- orale
- Presentation description
- plaquette(s) polyamide aluminium PVC-Aluminium de 6 comprimé(s)
- Marketing authorisation holder
- ARROW GENERIQUES
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 13 Jun 2022
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62459245CIP73023394CIP133400930233948Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| SUCCINATE DE SUMATRIPTANcomprimé | — | SA |
| SUMATRIPTANcomprimé | 50 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.